Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis

Evangelos Kalaitzakis; Riadh Sadik; Jens Juul Holst; Lena Ohman; Einar Björnsson

doi:10.1016/j.cgh.2008.11.022

Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis

Evangelos Kalaitzakis, Riadh Sadik, Jens Juul Holst, Lena Ohman, Einar Björnsson

Endocrinology and Metabolism

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

43 Citationer (Scopus)

Abstract

Udgivelsesdato: 2009-Mar

Originalsprog	Engelsk
Tidsskrift	Clinical Gastroenterology and Hepatology
Vol/bind	7
Udgave nummer	3
Sider (fra-til)	346-52
Antal sider	6
ISSN	1542-3565
DOI	https://doi.org/10.1016/j.cgh.2008.11.022
Status	Udgivet - 2008

Bibliografisk note

Keywords: Aged; Blood Chemical Analysis; Female; Gastric Emptying; Gastrointestinal Diseases; Gastrointestinal Hormones; Gastrointestinal Tract; Gastrointestinal Transit; Humans; Hyperglycemia; Liver Cirrhosis; Male; Middle Aged; Questionnaires

Adgang til dokumentet

10.1016/j.cgh.2008.11.022

Citationsformater

@article{311a3790335611df8ed1000ea68e967b,

title = "Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis",

abstract = "BACKGROUND & AIMS: Liver cirrhosis is associated with increased prevalence of gastrointestinal symptoms, insulin resistance, and altered gut transit. We aimed to assess the prevalence of gut transit abnormalities in patients with cirrhosis, compared with healthy controls, and to evaluate the relation of gut transit with gastrointestinal symptoms and postprandial glucose and hormone profiles. METHODS: Half gastric emptying, small bowel residence, and colonic filling times were measured with a validated radiologic procedure in 42 consecutive patients with cirrhosis. In a subgroup of 25 patients, gastrointestinal symptoms were evaluated by using a validated questionnaire and a caloric satiation test. Postprandial glucose, insulin, leptin, ghrelin, glucagon-like peptide 1, and PYY responses were also studied. Eighty-three healthy subjects served as controls for the transit studies and 10 for the hormone analyses. RESULTS: Of patients with cirrhosis, 24% had delayed gastric emptying and 38% had prolonged small bowel transit (P < .05 compared with controls). Delayed gastric emptying was related to postprandial fullness and prolonged small bowel transit to diarrhea and abdominal pain (P < .05 for all). The patients with cirrhosis had increased postprandial glucose, insulin, and glucagon-like peptide 1 responses and reduced postprandial ghrelin. Delayed gastric emptying was related to increased postprandial glucose and reduced postprandial ghrelin. Prolonged small bowel transit was related to increased postprandial glucose and insulin and reduced postprandial ghrelin. CONCLUSIONS: A high proportion of patients with cirrhosis exhibit delayed gastric emptying or small bowel transit, which is related to gastrointestinal symptoms. Postprandial hyperglycemia, hyperinsulinemia, and hypoghrelinemia might be linked to delayed gut transit in cirrhosis.",

author = "Evangelos Kalaitzakis and Riadh Sadik and Holst, {Jens Juul} and Lena Ohman and Einar Bj{\"o}rnsson",

note = "Keywords: Aged; Blood Chemical Analysis; Female; Gastric Emptying; Gastrointestinal Diseases; Gastrointestinal Hormones; Gastrointestinal Tract; Gastrointestinal Transit; Humans; Hyperglycemia; Liver Cirrhosis; Male; Middle Aged; Questionnaires",

year = "2008",

doi = "10.1016/j.cgh.2008.11.022",

language = "English",

volume = "7",

pages = "346--52",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B.Saunders Co.",

number = "3",

}

TY - JOUR

T1 - Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis

AU - Kalaitzakis, Evangelos

AU - Sadik, Riadh

AU - Holst, Jens Juul

AU - Ohman, Lena

AU - Björnsson, Einar

N1 - Keywords: Aged; Blood Chemical Analysis; Female; Gastric Emptying; Gastrointestinal Diseases; Gastrointestinal Hormones; Gastrointestinal Tract; Gastrointestinal Transit; Humans; Hyperglycemia; Liver Cirrhosis; Male; Middle Aged; Questionnaires

PY - 2008

Y1 - 2008

N2 - BACKGROUND & AIMS: Liver cirrhosis is associated with increased prevalence of gastrointestinal symptoms, insulin resistance, and altered gut transit. We aimed to assess the prevalence of gut transit abnormalities in patients with cirrhosis, compared with healthy controls, and to evaluate the relation of gut transit with gastrointestinal symptoms and postprandial glucose and hormone profiles. METHODS: Half gastric emptying, small bowel residence, and colonic filling times were measured with a validated radiologic procedure in 42 consecutive patients with cirrhosis. In a subgroup of 25 patients, gastrointestinal symptoms were evaluated by using a validated questionnaire and a caloric satiation test. Postprandial glucose, insulin, leptin, ghrelin, glucagon-like peptide 1, and PYY responses were also studied. Eighty-three healthy subjects served as controls for the transit studies and 10 for the hormone analyses. RESULTS: Of patients with cirrhosis, 24% had delayed gastric emptying and 38% had prolonged small bowel transit (P < .05 compared with controls). Delayed gastric emptying was related to postprandial fullness and prolonged small bowel transit to diarrhea and abdominal pain (P < .05 for all). The patients with cirrhosis had increased postprandial glucose, insulin, and glucagon-like peptide 1 responses and reduced postprandial ghrelin. Delayed gastric emptying was related to increased postprandial glucose and reduced postprandial ghrelin. Prolonged small bowel transit was related to increased postprandial glucose and insulin and reduced postprandial ghrelin. CONCLUSIONS: A high proportion of patients with cirrhosis exhibit delayed gastric emptying or small bowel transit, which is related to gastrointestinal symptoms. Postprandial hyperglycemia, hyperinsulinemia, and hypoghrelinemia might be linked to delayed gut transit in cirrhosis.

AB - BACKGROUND & AIMS: Liver cirrhosis is associated with increased prevalence of gastrointestinal symptoms, insulin resistance, and altered gut transit. We aimed to assess the prevalence of gut transit abnormalities in patients with cirrhosis, compared with healthy controls, and to evaluate the relation of gut transit with gastrointestinal symptoms and postprandial glucose and hormone profiles. METHODS: Half gastric emptying, small bowel residence, and colonic filling times were measured with a validated radiologic procedure in 42 consecutive patients with cirrhosis. In a subgroup of 25 patients, gastrointestinal symptoms were evaluated by using a validated questionnaire and a caloric satiation test. Postprandial glucose, insulin, leptin, ghrelin, glucagon-like peptide 1, and PYY responses were also studied. Eighty-three healthy subjects served as controls for the transit studies and 10 for the hormone analyses. RESULTS: Of patients with cirrhosis, 24% had delayed gastric emptying and 38% had prolonged small bowel transit (P < .05 compared with controls). Delayed gastric emptying was related to postprandial fullness and prolonged small bowel transit to diarrhea and abdominal pain (P < .05 for all). The patients with cirrhosis had increased postprandial glucose, insulin, and glucagon-like peptide 1 responses and reduced postprandial ghrelin. Delayed gastric emptying was related to increased postprandial glucose and reduced postprandial ghrelin. Prolonged small bowel transit was related to increased postprandial glucose and insulin and reduced postprandial ghrelin. CONCLUSIONS: A high proportion of patients with cirrhosis exhibit delayed gastric emptying or small bowel transit, which is related to gastrointestinal symptoms. Postprandial hyperglycemia, hyperinsulinemia, and hypoghrelinemia might be linked to delayed gut transit in cirrhosis.

U2 - 10.1016/j.cgh.2008.11.022

DO - 10.1016/j.cgh.2008.11.022

M3 - Journal article

C2 - 19200458

SN - 1542-3565

VL - 7

SP - 346

EP - 352

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 3

ER -